VEGFA and cancer: Although kidney damage evidenced by microangiopathy and proteinuria has been reported in adult human patients receiving anti-VEGF for cancer treatment (27), there is no research demonstrating renal damage in infants with ROP following intravitreal anti-VEGF injection treatment.